Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
Technology and Innovation
|
October 14, 2014
QUANTITATIVE MORPHOLOGICAL AND MOLECULAR PATHOLOGY OF THE HUMAN THYMUS CORRELATE WITH INFANT CAUSE OF DEATH
Mark C Lloyd, Nancy Burke, Fatemeh Kalantarpour, et al.
Journal of Neuroinflammation
|
September 13, 2016
Erratum to: Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
Jing-Ya Wang, Ya-Ni Huang, Chong-Chi Chiu, et al.
Journal of Neuroinflammation
|
June 30, 2016
Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
Jin-Ya Wang, Ya-Ni Huang, Chong-Chi Chiu, et al.
Frontiers in Cell and Developmental Biology
|
January 31, 2020
Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury
Miaad Bader, Yazhou Li, David Tweedie, et al.
Neurobiology of Disease
|
July 12, 2019
(-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice
Daniela Lecca, Miaad Bader, David Tweedie, et al.
Journal of Neuroscience Research
|
January 24, 2007
Apoptotic and behavioral sequelae of mild brain trauma in mice
David Tweedie, Anat Milman, Harold W Holloway, et al.
ACS Chemical Neuroscience
|
April 18, 2013
Gangliosides and ceramides change in a mouse model of blast induced traumatic brain injury
Amina S Woods, Benoit Colsch, Shelley N Jackson, et al.
Neurobiology of Disease
|
June 18, 2024
Corrigendum to "Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury" [Neurobiology of Disease Volume 124 (2019) 439-453 /YNBDI_4338]
Miaad Bader, Yazhou Li, Daniela Lecca, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 18, 2014
Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury
Nigel H Greig, David Tweedie, Lital Rachmany, et al.
Scientific Reports
|
June 18, 2017
Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degeneration
Lital Rachmany, David Tweedie, Vardit Rubovitch, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
Technology and Innovation
|
October 14, 2014
QUANTITATIVE MORPHOLOGICAL AND MOLECULAR PATHOLOGY OF THE HUMAN THYMUS CORRELATE WITH INFANT CAUSE OF DEATH
Mark C Lloyd, Nancy Burke, Fatemeh Kalantarpour, et al.
Journal of Neuroinflammation
|
September 13, 2016
Erratum to: Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
Jing-Ya Wang, Ya-Ni Huang, Chong-Chi Chiu, et al.
Journal of Neuroinflammation
|
June 30, 2016
Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
Jin-Ya Wang, Ya-Ni Huang, Chong-Chi Chiu, et al.
Frontiers in Cell and Developmental Biology
|
January 31, 2020
Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury
Miaad Bader, Yazhou Li, David Tweedie, et al.
Neurobiology of Disease
|
July 12, 2019
(-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice
Daniela Lecca, Miaad Bader, David Tweedie, et al.
Journal of Neuroscience Research
|
January 24, 2007
Apoptotic and behavioral sequelae of mild brain trauma in mice
David Tweedie, Anat Milman, Harold W Holloway, et al.
ACS Chemical Neuroscience
|
April 18, 2013
Gangliosides and ceramides change in a mouse model of blast induced traumatic brain injury
Amina S Woods, Benoit Colsch, Shelley N Jackson, et al.
Neurobiology of Disease
|
June 18, 2024
Corrigendum to "Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury" [Neurobiology of Disease Volume 124 (2019) 439-453 /YNBDI_4338]
Miaad Bader, Yazhou Li, Daniela Lecca, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 18, 2014
Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury
Nigel H Greig, David Tweedie, Lital Rachmany, et al.
Scientific Reports
|
June 18, 2017
Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degeneration
Lital Rachmany, David Tweedie, Vardit Rubovitch, et al.
Page
of 14